InspireMD (NSPR) Research & Development (2010 - 2025)
InspireMD posted quarterly Research & Development of $3.5 million for Q4 2025, down 5.9% year-on-year from $3.7 million in Q4 2024, and down 4.4% on a QoQ basis from $3.6 million in Q3 2025.
InspireMD (NSPR) has 16 years of Research & Development data on file, last reported at $3.5 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development fell 5.9% year-over-year to $3.5 million; the trailing twelve-month figure through Dec 2025 stood at $15.0 million (up 10.04% YoY), and the FY2025 full-year result was $15.0 million, up 10.04% from the prior year.
- Research & Development for Q4 2025 stood at $3.5 million, down from $3.6 million in the prior quarter.
- Across five years, Research & Development topped out at $4.1 million in Q1 2025 and bottomed at $839000.0 in Q1 2021.
- The 5-year median for Research & Development is $2.1 million (2022), against an average of $2.5 million.
- The widest annual swing landed in 2021, when Research & Development surged 190.54%; it then slipped 7.15% in 2025.
- A 5-year view of Research & Development shows it stood at $1.5 million in 2021, then jumped by 31.23% to $2.0 million in 2022, then climbed by 1.09% to $2.0 million in 2023, then soared by 81.47% to $3.7 million in 2024, then slipped by 5.9% to $3.5 million in 2025.
- The last three Research & Development figures came in at $3.5 million (Q4 2025), $3.6 million (Q3 2025), and $3.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | 3.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.48 Mn |
| Sep 30, 2025 | 3.64 Mn |
| Jun 30, 2025 | 3.83 Mn |
| Mar 31, 2025 | 4.06 Mn |
| Dec 31, 2024 | 3.69 Mn |
| Sep 30, 2024 | 3.92 Mn |
| Jun 30, 2024 | 3.40 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 1.99 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 2.01 Mn |
| Sep 30, 2022 | 2.06 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 1.68 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Sep 30, 2021 | 1.50 Mn |
| Jun 30, 2021 | 1.29 Mn |
| Mar 31, 2021 | 839,000.00 |
| Dec 31, 2020 | 720,000.00 |
| Sep 30, 2020 | 546,000.00 |
| Jun 30, 2020 | 444,000.00 |
| Mar 31, 2020 | 523,000.00 |
| Dec 31, 2019 | 522,000.00 |
| Sep 30, 2019 | 442,000.00 |
| Jun 30, 2019 | 865,000.00 |
| Mar 31, 2019 | 1.13 Mn |
| Dec 31, 2018 | 637,000.00 |
| Sep 30, 2018 | 416,000.00 |
| Jun 30, 2018 | 230,000.00 |
| Mar 31, 2018 | 252,000.00 |
| Dec 31, 2017 | 235,000.00 |
| Sep 30, 2017 | 288,000.00 |
| Jun 30, 2017 | 403,000.00 |
| Mar 31, 2017 | 350,000.00 |
| Dec 31, 2016 | 345,000.00 |
| Sep 30, 2016 | 289,000.00 |
| Jun 30, 2016 | 278,000.00 |
| Mar 31, 2016 | 379,000.00 |
| Dec 31, 2015 | 762,000.00 |
| Sep 30, 2015 | 781,000.00 |
| Jun 30, 2015 | 747,000.00 |
| Mar 31, 2014 | 2.58 Mn |
| Sep 30, 2013 | 1.54 Mn |
| Jun 30, 2013 | 1.05 Mn |
| Mar 31, 2013 | 907,000.00 |
| Dec 31, 2012 | 1.26 Mn |
| Sep 30, 2012 | 946,000.00 |
| Mar 31, 2012 | 1.35 Mn |
| Dec 31, 2011 | 834,000.00 |
| Sep 30, 2011 | 547,000.00 |
| Jun 30, 2011 | 750,000.00 |
| Mar 31, 2011 | 343,000.00 |
| Dec 31, 2010 | 369,000.00 |
| Sep 30, 2010 | 196,000.00 |
| Jun 30, 2010 | 372,000.00 |